Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT

Launched by CASE COMPREHENSIVE CANCER CENTER · May 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a program designed to help patients prepare for cancer surgery. It focuses on whether an exercise and nutrition plan can help people with advanced ovarian cancer or pancreatic cancer who are receiving chemotherapy. The goal is to see if participants can stick to this program, which may improve their health and outcomes before surgery.

To be eligible for this trial, participants need to be 65 years or older and have been diagnosed with advanced (Stage III or IV) epithelial ovarian cancer, fallopian tube cancer, or pancreatic adenocarcinoma. The study is currently recruiting participants, and anyone interested should be aware that those with serious health issues or a life expectancy of less than three months cannot join. If you participate, you can expect to engage in a structured plan to improve your fitness and nutrition while undergoing chemotherapy. This trial could be an important step in understanding how to best prepare patients for surgery during their cancer treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 65 and older
• • Patients with diagnosis of advanced (Stage III or IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer (EOC) undergoing neoadjuvant chemotherapy; OR Patients with diagnosis of pancreatic adenocarcinoma undergoing neoadjuvant chemotherapy
• Exclusion Criteria:
• • Life expectancy less than 3 months in the opinion of the treating physician
• • Patients unable to provide informed consent.
• • Wheelchair bound patients/ physical immobility.
• • Severe cardiopulmonary disease defined as NYHA class III or IV
• • Patients with malignant bowel obstruction who will require surgical intervention or nutritional support in the form of enteral or parenteral nutrition will also be excluded.
• • Patients with any other comorbidity or condition, which, in the opinion of the enrolling investigator, would place the patient at unnecessarily higher greater risk or burden, or participating in the study would not be in the best interests of the patient.